Ontology type: schema:ScholarlyArticle Open Access: True
2007-04-03
AUTHORSA Sultana, C Tudur Smith, D Cunningham, N Starling, D Tait, J P Neoptolemos, P Ghaneh
ABSTRACTThere is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI. More... »
PAGES1183-1190
http://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719
DOIhttp://dx.doi.org/10.1038/sj.bjc.6603719
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1019012220
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/17406358
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Combined Modality Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Meta-Analysis as Topic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pancreatic Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Randomized Controlled Trials as Topic",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Sultana",
"givenName": "A",
"id": "sg:person.01246775112.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Tudur Smith",
"givenName": "C",
"id": "sg:person.01261374732.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK",
"id": "http://www.grid.ac/institutes/grid.424926.f",
"name": [
"Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
],
"type": "Organization"
},
"familyName": "Cunningham",
"givenName": "D",
"id": "sg:person.01320161130.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK",
"id": "http://www.grid.ac/institutes/grid.424926.f",
"name": [
"Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
],
"type": "Organization"
},
"familyName": "Starling",
"givenName": "N",
"id": "sg:person.01136565472.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK",
"id": "http://www.grid.ac/institutes/grid.424926.f",
"name": [
"Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
],
"type": "Organization"
},
"familyName": "Tait",
"givenName": "D",
"id": "sg:person.0753037103.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Neoptolemos",
"givenName": "J P",
"id": "sg:person.012537142122.12",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Ghaneh",
"givenName": "P",
"id": "sg:person.07372440237.86",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/ncpgasthep0240",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050640294",
"https://doi.org/10.1038/ncpgasthep0240"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1995.364",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032504390",
"https://doi.org/10.1038/bjc.1995.364"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10434-999-0038-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022001684",
"https://doi.org/10.1007/s10434-999-0038-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2007-04-03",
"datePublishedReg": "2007-04-03",
"description": "There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51\u20130.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32\u20131.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI.",
"genre": "article",
"id": "sg:pub.10.1038/sj.bjc.6603719",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1017082",
"issn": [
"0007-0920",
"1532-1827"
],
"name": "British Journal of Cancer",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "8",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "96"
}
],
"keywords": [
"advanced pancreatic cancer",
"modality therapy",
"hazard ratio",
"pancreatic cancer",
"survival advantage",
"progression-free survival/time",
"systematic review",
"end point",
"primary end point",
"Secondary end points",
"important clinical differences",
"length of survival",
"adverse event data",
"care radiotherapy",
"Trials Register",
"overall survival",
"adverse events",
"survival benefit",
"modality treatment",
"clinical differences",
"wide CIs",
"relative risk",
"modality approach",
"chemoradiation",
"inclusion criteria",
"radiation therapy",
"chemotherapy",
"response rate",
"radiotherapy",
"therapy",
"survival data",
"trials",
"conference proceedings",
"cancer",
"survival",
"patients",
"review",
"progression",
"management",
"treatment",
"risk",
"Register",
"aim",
"radiation/",
"data",
"differences",
"consensus",
"database",
"criteria",
"benefits",
"rate",
"events",
"cis",
"Relevant",
"ratio",
"time",
"point",
"comparison",
"length",
"proceedings",
"advantages",
"approach"
],
"name": "Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy",
"pagination": "1183-1190",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1019012220"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/sj.bjc.6603719"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"17406358"
]
}
],
"sameAs": [
"https://doi.org/10.1038/sj.bjc.6603719",
"https://app.dimensions.ai/details/publication/pub.1019012220"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:06",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_443.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/sj.bjc.6603719"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'
This table displays all metadata directly associated to this object as RDF triples.
205 TRIPLES
22 PREDICATES
96 URIs
85 LITERALS
12 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1038/sj.bjc.6603719 | schema:about | N05418937ec734612aa67148d38e26df7 |
2 | ″ | ″ | N4c635050157443559d75b153d64e3e59 |
3 | ″ | ″ | Nd42619e9b8c34581bd7f89e5810b4e3d |
4 | ″ | ″ | Nd4da9499cd9645e78dd48275bbae3e0b |
5 | ″ | ″ | Nf59bb687dcb24a3aa9b994a1beb099ec |
6 | ″ | ″ | anzsrc-for:11 |
7 | ″ | ″ | anzsrc-for:1112 |
8 | ″ | schema:author | N242ffefcd67f40b1b0623ac2f2284215 |
9 | ″ | schema:citation | sg:pub.10.1007/s10434-999-0038-z |
10 | ″ | ″ | sg:pub.10.1038/bjc.1995.364 |
11 | ″ | ″ | sg:pub.10.1038/ncpgasthep0240 |
12 | ″ | schema:datePublished | 2007-04-03 |
13 | ″ | schema:datePublishedReg | 2007-04-03 |
14 | ″ | schema:description | There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI. |
15 | ″ | schema:genre | article |
16 | ″ | schema:inLanguage | en |
17 | ″ | schema:isAccessibleForFree | true |
18 | ″ | schema:isPartOf | N90659b1c99074721950e9dfda5ffa449 |
19 | ″ | ″ | Neee05385ea4342889814a5e819b5560d |
20 | ″ | ″ | sg:journal.1017082 |
21 | ″ | schema:keywords | Register |
22 | ″ | ″ | Relevant |
23 | ″ | ″ | Secondary end points |
24 | ″ | ″ | Trials Register |
25 | ″ | ″ | advanced pancreatic cancer |
26 | ″ | ″ | advantages |
27 | ″ | ″ | adverse event data |
28 | ″ | ″ | adverse events |
29 | ″ | ″ | aim |
30 | ″ | ″ | approach |
31 | ″ | ″ | benefits |
32 | ″ | ″ | cancer |
33 | ″ | ″ | care radiotherapy |
34 | ″ | ″ | chemoradiation |
35 | ″ | ″ | chemotherapy |
36 | ″ | ″ | cis |
37 | ″ | ″ | clinical differences |
38 | ″ | ″ | comparison |
39 | ″ | ″ | conference proceedings |
40 | ″ | ″ | consensus |
41 | ″ | ″ | criteria |
42 | ″ | ″ | data |
43 | ″ | ″ | database |
44 | ″ | ″ | differences |
45 | ″ | ″ | end point |
46 | ″ | ″ | events |
47 | ″ | ″ | hazard ratio |
48 | ″ | ″ | important clinical differences |
49 | ″ | ″ | inclusion criteria |
50 | ″ | ″ | length |
51 | ″ | ″ | length of survival |
52 | ″ | ″ | management |
53 | ″ | ″ | modality approach |
54 | ″ | ″ | modality therapy |
55 | ″ | ″ | modality treatment |
56 | ″ | ″ | overall survival |
57 | ″ | ″ | pancreatic cancer |
58 | ″ | ″ | patients |
59 | ″ | ″ | point |
60 | ″ | ″ | primary end point |
61 | ″ | ″ | proceedings |
62 | ″ | ″ | progression |
63 | ″ | ″ | progression-free survival/time |
64 | ″ | ″ | radiation therapy |
65 | ″ | ″ | radiation/ |
66 | ″ | ″ | radiotherapy |
67 | ″ | ″ | rate |
68 | ″ | ″ | ratio |
69 | ″ | ″ | relative risk |
70 | ″ | ″ | response rate |
71 | ″ | ″ | review |
72 | ″ | ″ | risk |
73 | ″ | ″ | survival |
74 | ″ | ″ | survival advantage |
75 | ″ | ″ | survival benefit |
76 | ″ | ″ | survival data |
77 | ″ | ″ | systematic review |
78 | ″ | ″ | therapy |
79 | ″ | ″ | time |
80 | ″ | ″ | treatment |
81 | ″ | ″ | trials |
82 | ″ | ″ | wide CIs |
83 | ″ | schema:name | Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy |
84 | ″ | schema:pagination | 1183-1190 |
85 | ″ | schema:productId | N1abcb045cab44ed489905555880b4284 |
86 | ″ | ″ | N45d77a2549314d48aaf28196782d22dd |
87 | ″ | ″ | Nc644450a76c04348a9d07d586f859e43 |
88 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1019012220 |
89 | ″ | ″ | https://doi.org/10.1038/sj.bjc.6603719 |
90 | ″ | schema:sdDatePublished | 2022-06-01T22:06 |
91 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
92 | ″ | schema:sdPublisher | Ncb455bb44bfb433bafd9c72c05547a25 |
93 | ″ | schema:url | https://doi.org/10.1038/sj.bjc.6603719 |
94 | ″ | sgo:license | sg:explorer/license/ |
95 | ″ | sgo:sdDataset | articles |
96 | ″ | rdf:type | schema:ScholarlyArticle |
97 | N05418937ec734612aa67148d38e26df7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
98 | ″ | schema:name | Combined Modality Therapy |
99 | ″ | rdf:type | schema:DefinedTerm |
100 | N1abcb045cab44ed489905555880b4284 | schema:name | doi |
101 | ″ | schema:value | 10.1038/sj.bjc.6603719 |
102 | ″ | rdf:type | schema:PropertyValue |
103 | N242ffefcd67f40b1b0623ac2f2284215 | rdf:first | sg:person.01246775112.38 |
104 | ″ | rdf:rest | N251347951f7a48b79d23f7eb7f5bb5f3 |
105 | N251347951f7a48b79d23f7eb7f5bb5f3 | rdf:first | sg:person.01261374732.97 |
106 | ″ | rdf:rest | N8c596cdeee9f45f899b1759de6aace1b |
107 | N3196037d45d942d898dbe8666de4897e | rdf:first | sg:person.01136565472.17 |
108 | ″ | rdf:rest | Nd35e01d710cc4f33b3497fed28d3f949 |
109 | N3e084061aca34d939ed331d0e7a4f443 | rdf:first | sg:person.012537142122.12 |
110 | ″ | rdf:rest | Nbc61b85fc9604568af6faa1fa13ddd32 |
111 | N45d77a2549314d48aaf28196782d22dd | schema:name | dimensions_id |
112 | ″ | schema:value | pub.1019012220 |
113 | ″ | rdf:type | schema:PropertyValue |
114 | N4c635050157443559d75b153d64e3e59 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
115 | ″ | schema:name | Humans |
116 | ″ | rdf:type | schema:DefinedTerm |
117 | N8c596cdeee9f45f899b1759de6aace1b | rdf:first | sg:person.01320161130.16 |
118 | ″ | rdf:rest | N3196037d45d942d898dbe8666de4897e |
119 | N90659b1c99074721950e9dfda5ffa449 | schema:issueNumber | 8 |
120 | ″ | rdf:type | schema:PublicationIssue |
121 | Nbc61b85fc9604568af6faa1fa13ddd32 | rdf:first | sg:person.07372440237.86 |
122 | ″ | rdf:rest | rdf:nil |
123 | Nc644450a76c04348a9d07d586f859e43 | schema:name | pubmed_id |
124 | ″ | schema:value | 17406358 |
125 | ″ | rdf:type | schema:PropertyValue |
126 | Ncb455bb44bfb433bafd9c72c05547a25 | schema:name | Springer Nature - SN SciGraph project |
127 | ″ | rdf:type | schema:Organization |
128 | Nd35e01d710cc4f33b3497fed28d3f949 | rdf:first | sg:person.0753037103.30 |
129 | ″ | rdf:rest | N3e084061aca34d939ed331d0e7a4f443 |
130 | Nd42619e9b8c34581bd7f89e5810b4e3d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
131 | ″ | schema:name | Meta-Analysis as Topic |
132 | ″ | rdf:type | schema:DefinedTerm |
133 | Nd4da9499cd9645e78dd48275bbae3e0b | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
134 | ″ | schema:name | Pancreatic Neoplasms |
135 | ″ | rdf:type | schema:DefinedTerm |
136 | Neee05385ea4342889814a5e819b5560d | schema:volumeNumber | 96 |
137 | ″ | rdf:type | schema:PublicationVolume |
138 | Nf59bb687dcb24a3aa9b994a1beb099ec | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
139 | ″ | schema:name | Randomized Controlled Trials as Topic |
140 | ″ | rdf:type | schema:DefinedTerm |
141 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
142 | ″ | schema:name | Medical and Health Sciences |
143 | ″ | rdf:type | schema:DefinedTerm |
144 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
145 | ″ | schema:name | Oncology and Carcinogenesis |
146 | ″ | rdf:type | schema:DefinedTerm |
147 | sg:journal.1017082 | schema:issn | 0007-0920 |
148 | ″ | ″ | 1532-1827 |
149 | ″ | schema:name | British Journal of Cancer |
150 | ″ | schema:publisher | Springer Nature |
151 | ″ | rdf:type | schema:Periodical |
152 | sg:person.01136565472.17 | schema:affiliation | grid-institutes:grid.424926.f |
153 | ″ | schema:familyName | Starling |
154 | ″ | schema:givenName | N |
155 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17 |
156 | ″ | rdf:type | schema:Person |
157 | sg:person.01246775112.38 | schema:affiliation | grid-institutes:grid.10025.36 |
158 | ″ | schema:familyName | Sultana |
159 | ″ | schema:givenName | A |
160 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38 |
161 | ″ | rdf:type | schema:Person |
162 | sg:person.012537142122.12 | schema:affiliation | grid-institutes:grid.10025.36 |
163 | ″ | schema:familyName | Neoptolemos |
164 | ″ | schema:givenName | J P |
165 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12 |
166 | ″ | rdf:type | schema:Person |
167 | sg:person.01261374732.97 | schema:affiliation | grid-institutes:grid.10025.36 |
168 | ″ | schema:familyName | Tudur Smith |
169 | ″ | schema:givenName | C |
170 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97 |
171 | ″ | rdf:type | schema:Person |
172 | sg:person.01320161130.16 | schema:affiliation | grid-institutes:grid.424926.f |
173 | ″ | schema:familyName | Cunningham |
174 | ″ | schema:givenName | D |
175 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16 |
176 | ″ | rdf:type | schema:Person |
177 | sg:person.07372440237.86 | schema:affiliation | grid-institutes:grid.10025.36 |
178 | ″ | schema:familyName | Ghaneh |
179 | ″ | schema:givenName | P |
180 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86 |
181 | ″ | rdf:type | schema:Person |
182 | sg:person.0753037103.30 | schema:affiliation | grid-institutes:grid.424926.f |
183 | ″ | schema:familyName | Tait |
184 | ″ | schema:givenName | D |
185 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30 |
186 | ″ | rdf:type | schema:Person |
187 | sg:pub.10.1007/s10434-999-0038-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1022001684 |
188 | ″ | ″ | https://doi.org/10.1007/s10434-999-0038-z |
189 | ″ | rdf:type | schema:CreativeWork |
190 | sg:pub.10.1038/bjc.1995.364 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1032504390 |
191 | ″ | ″ | https://doi.org/10.1038/bjc.1995.364 |
192 | ″ | rdf:type | schema:CreativeWork |
193 | sg:pub.10.1038/ncpgasthep0240 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1050640294 |
194 | ″ | ″ | https://doi.org/10.1038/ncpgasthep0240 |
195 | ″ | rdf:type | schema:CreativeWork |
196 | grid-institutes:grid.10025.36 | schema:alternateName | Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK |
197 | ″ | ″ | Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK |
198 | ″ | schema:name | Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK |
199 | ″ | ″ | Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK |
200 | ″ | rdf:type | schema:Organization |
201 | grid-institutes:grid.424926.f | schema:alternateName | Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK |
202 | ″ | ″ | Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK |
203 | ″ | schema:name | Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK |
204 | ″ | ″ | Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK |
205 | ″ | rdf:type | schema:Organization |